article
Beyond the phenotype: using AI to better understand disease
Claus Bendtsen at AstraZeneca reveals how AI can be used to improve our understanding of disease, to help identify the causes of conditions and aid in drug discovery.
List view / Grid view
Informatics
Filter the results
news
New CRISPR technique could alter the way we look at brain diseases
Researchers may have fundamentally altered the way scientists study brain diseases with new CRISPR technology.
news
New model predicts cognitive decline two years ahead
Researchers hope the system can choose the right patients to enroll in clinical trials, to speed discovery of drug treatments.
whitepaper
Whitepaper: CD4+ T-Cell Subsets
CD4+ T-cells play a central role in directing adaptive immune responses against invading microbial pathogens.
news
Sartorius debuts the Intellicyt iQue3 at CYTO® 2019
Sartorius debuts their new product, the Intellicyt iQue3, at this year's CYTO® conference and exhibition.
whitepaper
Whitepaper: The essential guide to managing laboratory samples
Mosaic Sample Management is Titian Software’s comprehensive, customisable, modular software product to control and monitor all aspects of sample storage, preparation and delivery.
video
Video: Ethical and regulatory use of biospecimens in the EU
Unique considerations surrounding the bureaucracy and oversight in the use of human biospecimens in the European Union.
news
Ten big pharma companies collaborate on data sharing AI
A new AI project marks the first time 10 pharmaceutical companies have agreed to share data to aid drug discovery.
news
High-res 3D structure of proteins inside living eukaryotic cells determined
Nuclear magnetic resonance measurement and state-of-the-art computational science reveal protein structures in higher eukaryotic cells.
news
UK drug discovery market ‘thriving’ says new report
A new report reveals a thriving service and supply sector for the UK in addition to its research and development biotechs.
article
AI-driven automated chemistry as a tool to accelerate drug discovery
Typically, early drug discovery campaigns start with the screening of chemical libraries to identify candidate chemotypes modulating a particular target and/or phenotype. Success of the primary screening depends on multiple factors related to both biology and chemistry. These include the target’s druggability, sensitivity and specificity of assay system, composition and…
news
New role unlocked for nervous system in regeneration
Using a computational model, researchers were able to explain, predict, and manipulate the regeneration of a flatworm body.
news
New mass spectrometry system for finding potential drugs
New method for computational mass spectrometry will speed up the discovery of natural products that could be used in medicines...
article
Drug discovery from the age of information to the age of intelligence
Data drives drug discovery, yet it continues to be among the biggest challenges faced by the industry.1 Experiments are often not repeatable and data interpretation is subject to the biases and limitations of human beings.
article
Lab Automation In-Depth Focus 2019
In this In-Depth Focus: realising the promise of laboratory automation in biomedical research, drug discovery from the age of information to the age of intelligence, and transforming drug discovery, development and delivery with flow chemistry.